User profiles for Glen J. Pearson

Glen J. Pearson

University of Alberta
Verified email at ualberta.ca
Cited by 5952

2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the …

…, R Ward, LA Leiter, E Lonn, DS Ng, GJ Pearson… - Canadian Journal of …, 2013 - Elsevier
Many developments have occurred since the publication of the widely-used 2009 Canadian
Cardiovascular Society (CCS) Dyslipidemia guidelines. Here, we present an updated …

2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult …

…, E Lonn, GBJ Mancini, D Ng, GJ Pearson… - Canadian Journal of …, 2009 - Elsevier
… Can J Cardiol Vol 25 No 10 October 2009 … Jacques Genest MD1, Ruth McPherson MD
PhD2, Jiri Frohlich MD3, Todd Anderson MD4, Norm Campbell MD4, André Carpentier MD5 …

2016 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult

TJ Anderson, J Grégoire, GJ Pearson, AR Barry… - Canadian Journal of …, 2016 - Elsevier
Since the publication of the 2012 guidelines new literature has emerged to inform decision-making.
The 2016 guidelines primary panel selected a number of clinically relevant …

2021 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults

GJ Pearson, G Thanassoulis, TJ Anderson… - Canadian journal of …, 2021 - Elsevier
… Author links open overlay panel Glen J. Pearson PharmD a ‡ , George Thanassoulis MD b
‡ , Todd J. Anderson MD c , Arden R. Barry PharmD d , Patrick Couture MD, PhD e , Natalie …

Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Consensus Working Group Update (2016)

…, RA Hegele, D Ng, GJ Pearson, J Pope… - Canadian Journal of …, 2016 - Elsevier
The Canadian Consensus Working Group has updated its evaluation of the literature pertaining
to statin intolerance and adverse effects. This overview introduces a pragmatic definition …

Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Working Group Consensus update

…, RA Hegele, DS Ng, GJ Pearson, J Pope - Canadian Journal of …, 2013 - Elsevier
The Proceedings of a Canadian Working Group Consensus Conference, first published in
2011, provided a summary of statin-associated adverse effects and intolerance and …

[HTML][HTML] Evolution in the practice of pharmacy—not a revolution!

GJ Pearson - Cmaj, 2007 - Can Med Assoc
All editorial matter in CMAJ represents the opinions of the authors and not necessarily those
of the Canadian Medical Association. and training, experience, collaborative relationships …

Canadian Cardiovascular Society position statement on familial hypercholesterolemia: update 2018

…, M Gupta, P Couture, GJ Pearson, J Bergeron… - Canadian Journal of …, 2018 - Elsevier
Familial hypercholesterolemia (FH) is the most common monogenic disorder causing premature
atherosclerotic cardiovascular disease. It affects 1 in 250 individuals worldwide, and of …

Familial hypercholesterolemia: Review of diagnosis, screening, and treatment

RD Turgeon, AR Barry, GJ Pearson - Canadian family physician, 2016 - cfp.ca
Objective To summarize the pathophysiology, epidemiology, screening, diagnosis, and
treatment of familial hypercholesterolemia (FH). Quality of evidence A PubMed search was …

Correlation of cardiovascular magnetic resonance imaging findings and endomyocardial biopsy results in patients undergoing screening for heart transplant rejection

…, DH Kim, M Mengel, M Haykowsky, GJ Pearson… - The Journal of Heart and …, 2015 - Elsevier
Background Endomyocardial biopsy (EMB) is the current gold standard to screen for heart
transplant rejection but has important risks and limitations. Cardiovascular magnetic …